New insights for the use of quercetin analogs in cancer treatment

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Sharma A, Gupta H. Quercetin – a flavonoid. Chron. Young Sci. 1(1), 10–15 (2010).
  Google Scholar
• 2 Sak K. Chemotherapy and dietary phytochemical agents. Chemother. Res. Pract. doi:10.1155/2012/282570 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 3 Kaur C, Kapoor HC. Antioxidants in fruits and vegetables – the millenium's health. Int. J. Food Sci. Technol. 3(6), 703–725 (2001).
  Google Scholar
• 4 Ferry DR, Smith A, Malkhandi J et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2(4), 659–668 (1996).
  Medline CASGoogle Scholar
• 5 Verma AK, Johnson JA, Gould MN et al. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 48(20), 5754–5758 (1988).
  Medline CASGoogle Scholar
• 6 Deschner EE, Ruperto J, Wong G et al. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12(7), 1193–1196 (1991).
  Medline CASGoogle Scholar
• 7 Pereira MA, Grubbs CJ, Barnes LH et al. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz(a)anthracene-induced mammary cancer in rats. Carcinogenesis 17(6), 1305–1311 (1996).
  Medline CASGoogle Scholar
• 8 Perez-Vizcaino F, Ibarra M, Cogolludo AL et al. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J. Pharmacol. Exp. Ther. 302(1), 66–72 (2002).
  Medline CASGoogle Scholar
• 9 Angelone T, Pasqua T, Di Majo D et al. Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols. Nutr. Metab. Cardiovasc. Dis. 21(5), 362–371 (2011).
  Medline CASGoogle Scholar
• 10 Pignatelli P, Pulcinelli FM, Celestini A et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr. 72(5), 1150–1155 (2000).
  Medline CASGoogle Scholar
• 11 Rice-Evans CA, Miller NJ, Paganga G. Structure–antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20(7), 933–956 (1996).
  Medline CASGoogle Scholar
• 12 Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417(1), 12–17 (2003).
  Medline CASGoogle Scholar
• 13 Liu H, Zhang L, Lu S. Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats. Molecules 17(4), 4281–4291 (2012).
  Medline CASGoogle Scholar
• 14 Moskaug JO, Carlsen H, Myhrstad M et al. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev. 125(4), 315–324 (2004).
  Medline CASGoogle Scholar
• 15 Abdelmoaty MA, Ibrahim MA, Ahmed NS et al. Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J. Clin. Biochem. 25(2), 188–192 (2010).
  Medline CASGoogle Scholar
• 16 Stephen-Cole L. Quercetin: a review of clinical applications. Clin. Sci. 40, 234–238 (1998). • Summarizes quercetin's biological applications.
  Google Scholar
• 17 Carocci A, Catalano A, Sinicropi MS. Melatonergic drugs in development. Clin. Pharmacol. 6, 127–137 (2014).
  Medline CASGoogle Scholar
• 18 Borska S, Drag-Zalesinska M, Wysocka T et al. Antiproliferative and pro-apoptotic effects of quercetin on human pancreatic carcinoma cell lines EPP85–181P and EPP85–181RDB. Folia Histochem. Cytobiol. 48(2), 222–229 (2010). • Highlights quercetin's involvement in cancer prevention.
  MedlineGoogle Scholar
• 19 Choi JA, Kim JY, Lee JY et al. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol. 19(4), 837–844 (2001). • Summarizes quercetin's mechanism of action in cancer cells replicative cycle.
  Medline CASGoogle Scholar
• 20 Ong CS, Tran E, Nguyen TT et al. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol. Rep. 11(3), 727–733 (2004).
  Medline CASGoogle Scholar
• 21 Lugli E, Ferraresi R, Roat E et al. Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. Leuk. Res. 33(1), 140–150 (2009).
  Medline CASGoogle Scholar
• 22 Han Q, Yang R, Li J et al. Enhancement of biological activities of nanostructured hydrophobic drug species. Nanoscale 4(6), 2078–2082 (2012).
  Medline CASGoogle Scholar
• 23 Larocca LM, Teofili L, Leone G et al. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. Br. J. Haematol. 79(4), 562–566 (1991).
  Medline CASGoogle Scholar
• 24 Psahoulia FH, Moumtzi S, Roberts ML et al. Quercetin mediates preferential degradation of oncogenic RAS and causes autophagy in HA-RAS-transformed human colon cells. Carcinogenesis 28(5), 1021–1031 (2007).
  Medline CASGoogle Scholar
• 25 Nakanoma T, Ueno M, Iida M et al. Effects of quercetin on the heat-induced cytotoxicity of prostate cancer cells. Int. J. Urol. 8(11), 623–630 (2001).
  Medline CASGoogle Scholar
• 26 Chien SY, Wu YC, Chung JG et al. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum. Exp. Toxicol. 28(8), 493–503 (2009).
  Medline CASGoogle Scholar
• 27 Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro 23(5), 797–807 (2009).
  Medline CASGoogle Scholar
• 28 Murtaza I, Marra G, Schlapbach R et al. A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnol. Appl. Biochem. 45(Pt 1), 29–36 (2006).
  Medline CASGoogle Scholar
• 29 Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 143(2), 383–396 (2012).
  Medline CASGoogle Scholar
• 30 Baghel SS, Shrivastava N, Baghel RS et al. A review of quercetin: antioxidant and anticancer properties. World J. Pharm. Pharm. Sci. 1(1), 146–160 (2012). •• Reinforces the concept that quercetin may represent a promising tool for cancer treatment as well as an effective antioxidant agent.
  CASGoogle Scholar
• 31 Oh SJ, Kim O, Lee JS et al. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food Chem. Toxicol. 48(11), 3227–3234 (2010).
  Medline CASGoogle Scholar
• 32 Jagadeeswaran R, Thirunavukkarasu C, Gunasekaran P et al. In vitro studies on the selective cytotoxic effect of crocetin and quercetin. Fitoterapia 71(4), 395–399 (2000).
  Medline CASGoogle Scholar
• 33 Bansal T, Jaggi M, Khar RK et al. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J. Pharm. Pharm. Sci. 12(1), 46–78 (2009).
  Medline CASGoogle Scholar
• 34 Lamson DW, Brignall MS. Antioxidants and cancer, part III: quercetin. Altern. Med. Rev. 5(3), 196–208 (2000).
  Medline CASGoogle Scholar
• 35 Hoffman R, Graham L, Newlands ES. Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562. Br. J. Cancer 59(3), 347–348 (1989).
  Medline CASGoogle Scholar
• 36 Minaei A, Sabzichi M, Ramezani F et al. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol. Biol. Rep. 43(2), 99–105 (2016).
  Medline CASGoogle Scholar
• 37 Atashpour S, Fouladdel S, Movahhed TK et al. Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iran. J. Basic Med. Sci. 18(7), 635–643 (2015).
  MedlineGoogle Scholar
• 38 Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585(2–3), 325–337 (2008).
  Medline CASGoogle Scholar
• 39 Seufi AM, Ibrahim SS, Elmaghraby TK et al. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J. Exp. Clin. Cancer Res. 28, 80 (2009).
  MedlineGoogle Scholar
• 40 Olayinka ET, Ore A, Ola OS et al. Protective effect of quercetin on melphalan-induced oxidative stress and impaired renal and hepatic functions in rat. Chemother. Res. Pract. 2014, 936526 (2014).
  MedlineGoogle Scholar
• 41 Shirai M, Yamanishi R, Moon JH et al. Effect of quercetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Biosci. Biotechnol. Biochem. 66(5), 1015–1021 (2002).
  Medline CASGoogle Scholar
• 42 Atef E, El-Baky A. Quercetin protective action on oxidative stress, sorbitol, insulin risistance and cells function in expermintal diabetic rats. Int. J. Pharm. Stud. Res. 2(2), 11–18 (2011).
  Google Scholar
• 43 Hossion AML, Zamami Y, Kandahary RK et al. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents. J. Med. Chem. 54(11), 3686–3703 (2010).
  Google Scholar
• 44 Sak K. Site-specific anticancer effects of dietary flavonoid quercetin. Nutr. Cancer 66(2), 177–193 (2014).
  Medline CASGoogle Scholar
• 45 Jaramillo S, Lopez S, Varela LM et al. The flavonol isorhamnetin exhibits cytotoxic effects on human colon cancer cells. J. Agric. Food Chem. 58(20), 10869–10875 (2010).
  Medline CASGoogle Scholar
• 46 Bulzomi P, Galluzzo P, Bolli A et al. The pro-apoptotic effect of quercetin in cancer cell lines requires ERbeta-dependent signals. J. Cell. Physiol. 227(5), 1891–1898 (2012). • Shows how quercetin induces apoptosis in cancer cells.
  Medline CASGoogle Scholar
• 47 Shirai M, Kawai Y, Yamanishi R et al. Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells. Free Radic. Res. 40(10), 1047–1053 (2006).
  Medline CASGoogle Scholar
• 48 O'Leary KA, Day AJ, Needs PW et al. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem. Pharmacol. 65(3), 479–491 (2003).
  MedlineGoogle Scholar
• 49 Poor M, Zrinyi Z, Koszegi T. Structure related effects of flavonoid aglycones on cell cycle progression of HepG2 cells: metabolic activation of fisetin and quercetin by catechol-O-methyltransferase (COMT). Biomed. Pharmacother. 83, 998–1005 (2016).
  Medline CASGoogle Scholar
• 50 Mattarei A, Biasutto L, Rastrelli F et al. Regioselective O-derivatization of quercetin via ester intermediates. An improved synthesis of rhamnetin and development of a new mitochondriotropic derivative. Molecules 15(7), 4722–4736 (2010).
  Medline CASGoogle Scholar
• 51 Kim MK, Park KS, Chong Y. Remarkable stability and cytostatic effect of a quercetin conjugate. 3,7-bis-O-pivaloxymethyl (POM) quercetin. ChemMedChem. 7(2), 229–232 (2012).
  Medline CASGoogle Scholar
• 52 Kim MK, Park KS, Lee C et al. Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety. J. Med. Chem. 53(24), 8597–8607 (2010).
  Medline CASGoogle Scholar
• 53 Krol W, Dworniczak S, Pietsz G et al. Synthesis and tumoricidal activity evaluation of new morin and quercetin sulfonic derivatives. Acta Pol. Pharm. 59(1), 77–79 (2002).
  Medline CASGoogle Scholar
• 54 Grande F, Parisi OI, Mordocco RA et al. Quercetin derivatives as novel antihypertensive agents: synthesis and physiological characterization. Eur. J. Pharm. Sci. 82, 161–170 (2016). •• Describes the synthesis of quercetin derivatives.
  Medline CASGoogle Scholar
• 55 Picq M, Prigent AF, Nemoz G et al. Pentasubstituted quercetin analogues as selective inhibitors of particulate 3′:5′-cyclic-AMP phosphodiesterase from rat brain. J. Med. Chem. 25(10), 1192–1198 (1982).
  Medline CASGoogle Scholar
• 56 Lu C, Huang F, Li Z et al. Synthesis and bioactivity of quercetin aspirinates. Bull. Kor. Chem. Soc. 35(2), 518–520 (2014).
  CASGoogle Scholar
• 57 Bouktaib M, Lebrun S, Atmanib A et al. Hemisynthesis of all the O-monomethylated anologues of quercetin including the major methebolites, through selective protection of phenolic functions. Tetrahedron 58(44), 10001–10009 (2002).
  CASGoogle Scholar
• 58 Redinbo MR, Stewart L, Kuhn P et al. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279(5356), 1504–1513 (1998).
  Medline CASGoogle Scholar
• 59 Iacopetta D, Rosano C, Puoci F et al. Multifaceted properties of 1,4-dimethylcarbazoles: focus on trimethoxybenzamide and trimethoxyphenylurea derivatives as novel human topoisomerase II inhibitors. Eur. J. Pharm. Sci. 96, 263–272 (2017).
  Medline CASGoogle Scholar
• 60 Verdonk JC, Ric de Vos CH, Verhoeven HA et al. Regulation of floral scent production in petunia revealed by targeted metabolomics. Phytochemistry 62(6), 997–1008 (2003).
  Medline CASGoogle Scholar
• 61 Pettersen EF, Goddard TD, Huang CC et al. UCSF Chimera – a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605–1612 (2004).
  Medline CASGoogle Scholar
• 62 Sala M, Chimento A, Saturnino C et al. Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorg. Med. Chem. Lett. 23(17), 4990–4995 (2013).
  Medline CASGoogle Scholar
• 63 Sirignano E, Saturnino C, Botta A et al. Synthesis, characterization and cytotoxic activity on breast cancer cells of new half-titanocene derivatives. Bioorg. Med. Chem. Lett. 23(11), 3458–3462 (2013).
  Medline CASGoogle Scholar
• 64 Iacopetta D, Carocci A, Sinicropi MS et al. Old drug scaffold, new activity: thalidomide-correlated compounds exert different effects on breast cancer cell growth and progression. ChemMedChem. 12(5), 381–389 (2017).
  Medline CASGoogle Scholar
• 65 Carocci A, Catalano A, Bruno C et al. N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II. Bioorg. Med. Chem. 21(4), 847–851 (2013).
  Medline CASGoogle Scholar
• 66 Sinicropi MS, Caruso A, Conforti F et al. Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives. J. Enzyme Inhib. Med. Chem. 24(5), 1148–1153 (2009).
  Medline CASGoogle Scholar
• 67 Criddle DN, Gillies S, Baumgartner-Wilson HK et al. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J. Biol. Chem. 281(52), 40485–40492 (2006).
  Medline CASGoogle Scholar
• 68 Spizzirri U, Altimari I, Puoci F et al. Innovative antioxidant thermo-responsive hydrogels by radical grafting of catechin on inulin chain. Carbohydr. Polym. 84(1), 517–523 (2011).
  CASGoogle Scholar
• 69 Sudan S, Rupasinghe HP. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells. Anticancer Res. 34(4), 1691–1699 (2014).
  Medline CASGoogle Scholar
• 70 Madden KR, Champoux JJ. Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res. 52(3), 525–532 (1992).
  Medline CASGoogle Scholar
• 71 Ferlin MG, Marzano C, Gandin V et al. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure–activity relationships. ChemMedChem 4(3), 363–377 (2009).
  Medline CASGoogle Scholar
• 72 Trachootham D, Zhou Y, Zhang H et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10(3), 241–252 (2006).
  Medline CASGoogle Scholar
• 73 Sanpui P, Chattopadhyay A, Ghosh SS. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl. Mater. Interfaces 3(2), 218–228 (2011).
  Medline CASGoogle Scholar
• 74 Kedare SB, Singh RP. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 48(4), 412–422 (2011).
  Medline CASGoogle Scholar